analyst
NG
NASDAQ · NGNE
Neurogene Inc.
Healthcare · Biotechnology
$25.65
Down-$0.90 (-3.39%)
Updated Oct 3, 2026, 11:44 AM
SID Score
4.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 329.3M
- P/E ratio
- -5.29
- Dividend yield
- 0.00%
- 52-week range
- $18.23 – $43.66
- Volume
- 401.64K
- Avg. volume
- 231.35K
Price performance · NGNE
NGNE price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 2, 2026
NGNE closed at $25.65 after 20 trading sessions, down 33.55% for the selected period.
- Last close
- $25.65
- Period change
- -33.55%
- Period low
- $25.65
- Period high
- $38.60
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 2, 2026 | $26.95 | $26.95 | $24.86 | $25.65 | 401.64K |
| Oct 1, 2026 | $27.68 | $28.54 | $26.44 | $26.55 | 182.6K |
| Sep 30, 2026 | $28.52 | $28.615 | $27.40 | $27.82 | 160.13K |
| Sep 29, 2026 | $28.50 | $29.16 | $28.05 | $28.39 | 176.74K |
| Sep 28, 2026 | $28.20 | $28.82 | $27.64 | $28.48 | 176.39K |
| Sep 25, 2026 | $31.31 | $31.31 | $28.23 | $28.31 | 200.11K |
| Sep 24, 2026 | $30.85 | $31.78 | $30.43 | $31.25 | 374.88K |
| Sep 23, 2026 | $33.49 | $33.53 | $30.09 | $30.93 | 276.19K |
| Sep 22, 2026 | $32.94 | $34.45 | $32.79 | $33.60 | 1.22M |
| Sep 21, 2026 | $32.09 | $32.84 | $31.2112 | $32.57 | 325.53K |
| Sep 18, 2026 | $32.49 | $33.15 | $31.86 | $32.09 | 1.39M |
| Sep 17, 2026 | $35.36 | $35.635 | $32.04 | $32.41 | 171.61K |
| Sep 16, 2026 | $34.04 | $34.86 | $33.525 | $34.67 | 232.13K |
| Sep 15, 2026 | $35.04 | $35.04 | $33.46 | $33.69 | 147.61K |
| Sep 14, 2026 | $35.92 | $36.28 | $34.70 | $35.21 | 194.67K |
| Sep 11, 2026 | $36.50 | $37.64 | $35.38 | $35.48 | 181.39K |
| Sep 10, 2026 | $37.51 | $38.25 | $36.07 | $36.12 | 177.11K |
| Sep 9, 2026 | $38.04 | $40.42 | $37.86 | $37.88 | 193.18K |
| Sep 8, 2026 | $37.79 | $38.75 | $36.68 | $38.13 | 228.47K |
| Sep 4, 2026 | $37.25 | $39.38 | $36.5573 | $38.60 | 205.63K |
Latest NGNE news
The latest Smart Investors Daily articles mentioning NGNE.
Stock researchCompany · Financials
Company
Market Activity
Research & News
Loading stock research…

